25-Hydroxyvitamin D potentializes extracellular cathelicidin release from human PBMC stimulated ex vivo with either bacterial (LPS) or viral (P: IC) mimetics

被引:4
作者
Al Dekwer, Sahar [1 ]
Goncalves-Mendes, Nicolas [1 ]
Bingula, Rea [1 ]
Martinroche, Guillaume [1 ]
Lanchais, Kassandra [1 ]
Rouge, Stephanie [1 ]
Farges, Marie-Chantal [1 ]
Rossary, Adrien [1 ]
Diab-Assaf, Mona [2 ]
Vasson, Marie-Paule [1 ,3 ]
Talvas, Jeremie [1 ]
机构
[1] Univ Clermont Auvergne, CRNH Auvergne, INRA, UMR 1019,Human Nutr Unit, F-63000 Clermont Ferrand, France
[2] Lebanese Univ, Fac Sci 2, Fanar, Lebanon
[3] CHU, Ctr Jean Perrin, Nutr Unit, F-63000 Clermont Ferrand, France
关键词
Calcidiol supplementation; Calcitriol cellular production; Microbial defense enhancement; Infectious disease prevention; VITAMIN-D SUPPLEMENTATION; ANTIMICROBIAL PEPTIDE; MESSENGER-RNA; EXPRESSION; LL-37; PROTEINASE-3; TLR2; D-3;
D O I
10.1007/s13105-021-00868-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human cathelicidin refers to the cationic antimicrobial peptide hCAP18/LL-37. LL-37 is formed by cleavage of the propeptide hCAP18 coded with CAMP gene. The active form of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)D), has been shown to induce the CAMP gene expression through promoter activation. We previously failed to demonstrate in a clinical trial that supplementation of 25-hydroxyvitamin D (25(OH)D) improves LL-37 serum levels. The aim of this work was to evaluate the impact of 25(OH)D supplementation on intracellular expression of CAMP and secretion of LL-37 in an ex vivo model using the peripheral blood mononuclear cells (PBMC). PBMC collected from healthy donors and incubated with different concentrations of 25(OH)D (0 ng/ml: control (D0); 25 ng/ml: deficient (D25); 75 ng/ml: physiological (D75); 125 ng/ml: supraphysiological (D125)) were stimulated or not with lipopolysaccharide (LPS, 100 ng/ml) or synthetic double-stranded RNA Poly (I: C) (PIC, 10 mu g/ml). The intracellular expressions of the CAMP gene and the hCAP18 peptide were measured respectively after 24-h and 48-h incubation periods. The concentration of LL-37 was determined in the culture medium after 48-h incubation. 25(OH)D significantly induced CAMP gene expression at 24 h with a maximum effect at a dose of D125 in either unstimulated (tenfold expression) or stimulated (LPS: 100-fold expression; PIC: 15-fold expression) conditions. Intracellular hCAP18 peptide was overexpressed at 48 h under unstimulated (1.5-fold, D125) and stimulated conditions, LPS (twofold, D125) and PIC (2.5-fold, D125). The secretion of LL-37 in the culture medium was significantly induced by 25(OH)D only in both stimulated (LPS and PIC) conditions in a dose-dependent manner. Our results demonstrate that 25(OH)D incubation increases intracellular expression of CAMP and hCAP18, but extracellular secretion of LL-37 antimicrobial peptide is increased by 25(OH)D only when PBMC from healthy donors were stimulated with bacterial or viral immune mimetic.
引用
收藏
页码:335 / 342
页数:8
相关论文
共 36 条
[11]   Influence of Vitamin D Supplementation by Simulated Sunlight or Oral D3 on Respiratory Infection during Military Training [J].
Harrison, Sophie E. ;
Oliver, Samuel J. ;
Kashi, Daniel S. ;
Carswell, Alexander T. ;
Edwards, Jason P. ;
Wentz, Laurel M. ;
Roberts, Ross ;
Tang, Jonathan C. Y. ;
Izard, Rachel M. ;
Jackson, Sarah ;
Allan, Donald ;
Rhodes, Lesley E. ;
Fraser, William D. ;
Greeves, Julie P. ;
Walsh, Neil P. .
MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2021, 53 (07) :1505-1516
[12]   Decreased serum LL-37 and vitamin D3 levels in atopic dermatitis: relationship between IL-31 and oncostatin M [J].
Kanda, N. ;
Hau, C. S. ;
Tada, Y. ;
Sato, S. ;
Watanabe, S. .
ALLERGY, 2012, 67 (06) :804-812
[13]   1,25-DIHYDROXYVITAMIN-D3 PRODUCTION AND VITAMIN-D3 RECEPTOR EXPRESSION ARE DEVELOPMENTALLY-REGULATED DURING DIFFERENTIATION OF HUMAN MONOCYTES INTO MACROPHAGES [J].
KREUTZ, M ;
ANDREESEN, R ;
KRAUSE, SW ;
SZABO, A ;
RITZ, E ;
REICHEL, H .
BLOOD, 1993, 82 (04) :1300-1307
[14]   miRNA-130a regulates C/EBP-ε expression during granulopoiesis [J].
Larsen, Maria T. ;
Hager, Mattias ;
Glenthoj, Andreas ;
Asmar, Fazila ;
Clemmensen, Stine N. ;
Mora-Jensen, Helena ;
Borregaard, Niels ;
Cowland, Jack B. .
BLOOD, 2014, 123 (07) :1079-1089
[15]   NF-κB-Dependent Induction of Cathelicidin-Related Antimicrobial Peptide in Murine Mast Cells by Lipopolysaccharide [J].
Li, Guiming ;
Domenico, Joanne ;
Jia, Yi ;
Lucas, Joseph J. ;
Gelfand, Erwin W. .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2009, 150 (02) :122-132
[16]   Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response [J].
Liu, PT ;
Stenger, S ;
Li, HY ;
Wenzel, L ;
Tan, BH ;
Krutzik, SR ;
Ochoa, MT ;
Schauber, J ;
Wu, K ;
Meinken, C ;
Kamen, DL ;
Wagner, M ;
Bals, R ;
Steinmeyer, A ;
Zügel, U ;
Gallo, RL ;
Eisenberg, D ;
Hewison, M ;
Hollis, BW ;
Adams, JS ;
Bloom, BR ;
Modlin, RL .
SCIENCE, 2006, 311 (5768) :1770-1773
[17]   Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method [J].
Livak, KJ ;
Schmittgen, TD .
METHODS, 2001, 25 (04) :402-408
[18]   A comparison of vitamin D and cathelicidin (LL-37) levels between patients with active TB and their healthy contacts in a high HIV prevalence setting: a prospective descriptive study [J].
Lungu, Patrick Saili ;
Kilembe, William ;
Lakhi, Shabir ;
Sukwa, Thomas ;
Njelesani, Evarist ;
Zumla, Alimuddin, I ;
Mwaba, Peter .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2022, 116 (04) :336-343
[19]   Activation of antioxidant defences of human mammary epithelial cells under leptin depend on neoplastic state [J].
Mahbouli, Sinda ;
Talvas, Jeremie ;
der Vartanian, Audrey ;
Ortega, Sophie ;
Rouge, Stephanie ;
Vasson, Marie-Paule ;
Rossary, Adrien .
BMC CANCER, 2018, 18
[20]   Crosstalk between vitamin D axis, inflammation and host immunity mechanisms: A prospective study [J].
Meca, Andreea-Daniela ;
Stefanescu, Simona ;
Bogdan, Maria ;
Turcu-Stiolica, Adina ;
Nitu, Floarea Mimi ;
Matei, Marius ;
Cioboata, Ramona ;
Buga, Ana Maria ;
Pisoschi, Catalina-Gabriela .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (06)